bioRxiv
chromMAGMA: regulatory element-centric interrogation of risk variants
Publication
, Preprint
Nameki, R; Shetty, A; Dareng, E; Tyrer, J; Lin, X; the Ovarian Cancer Association Consortium; Pharoah, P; Corona, R; Kar, S; Lawrenson, K
2022
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Nameki, R., Shetty, A., Dareng, E., Tyrer, J., Lin, X., the Ovarian Cancer Association Consortium, … Lawrenson, K. (2022). chromMAGMA: regulatory element-centric interrogation of risk variants. bioRxiv. https://doi.org/10.1101/2022.01.21.477270
Nameki, Robbin, Anamay Shetty, Eileen Dareng, Jonathan Tyrer, Xianzhi Lin, the Ovarian Cancer Association Consortium, Paul Pharoah, Rosario Corona, Siddhartha Kar, and Kate Lawrenson. “chromMAGMA: regulatory element-centric interrogation of risk variants.” BioRxiv, 2022. https://doi.org/10.1101/2022.01.21.477270.
Nameki R, Shetty A, Dareng E, Tyrer J, Lin X, the Ovarian Cancer Association Consortium, et al. chromMAGMA: regulatory element-centric interrogation of risk variants. bioRxiv. 2022.
Nameki, Robbin, et al. “chromMAGMA: regulatory element-centric interrogation of risk variants.” BioRxiv, 2022. Epmc, doi:10.1101/2022.01.21.477270.
Nameki R, Shetty A, Dareng E, Tyrer J, Lin X, the Ovarian Cancer Association Consortium, Pharoah P, Corona R, Kar S, Lawrenson K. chromMAGMA: regulatory element-centric interrogation of risk variants. bioRxiv. 2022.